Vascular Embolization Market By Product (Embolic Agents, Embolization Devices), By Application (Oncology, Peripheral Vascular Diseases, Urology and Nephrology, Neurology, Others), By End User (Hospitals and Clinics, Ambulatory Surgical Centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031
The global vascular embolization market was valued at $3,682.73 million in 2021, and is projected to reach $7,780.98 million by 2031, registering a CAGR of 7.7% from 2022 to 2031.
A minimally invasive process called embolization inhibits blood flow in certain places. The procedure is carried out while preserving regular blood flow in the surrounding areas to protect tissues while managing problematic bleeding. When a blood vessel becomes blocked, it is called an embolism, and when a blood vessel is purposefully blocked for medical reasons, it is called an embolization operation. A catheter-based technique called coil embolization enables exact blockage of aberrant blood flow in a blood artery. An artery, typically in the groin, is entered using a catheter with a metallic occluding coil (the femoral artery).
The aberrant blood vessel is then reached by the advancement. By moving forward with blood flow and penetrating deeper into the vascular bed to locations where a catheter or coil may not reach, liquid embolic agents have the capacity to fill the target vessel and cause vascular blockage. Detachable balloons have an advantage over other embolization techniques such as embolization through detachable balloons is reversible until the balloon is removed. Large arteries and fistulae can be instantly and precisely occluded .The growth of global vascular embolization market is majorly driven by an alarming increase in prevalence of vascular diseases. Increase in improvements in vascular disease treatment by embolization techniques and products also accelerates the growth of the vascular embolization market.
Moreover, increased success rate of embolization plugs in non-invasive procedures for vascular occlusion, its availability as a viable alternative to conventional procedure and other technological advancement in this is anticipated to drive the market even more. To site an example, the Amplatzer Plug 4 by St. Jude Medical, Inc. is easily available in the market. However, high cost of vascular embolization, complications associated with it, hinders the growth of the market. In addition, therapies like chemotherapy, and radiation therapy are preferred options in the treatment of cancer because people are generally aware of traditional cancer treatments, advanced treatment options are not widely used and oncologists are reluctant to switch from traditional treatment options. In addition, risk of lodging an embolic agent in the wrong place can deprive normal tissues of oxygen. These are the factors which will negatively impact the growth of the market.
The global vascular embolization market is segmented into product, application, and end user. By product, the market is categorized into embolic agents and embolization devices. Embolic agents and Embolic Devices are further sub categorized into liquid embolic agents and microspheres. And embolization devices are classified into coils, detachable balloons, embolic plugs, and support devices.
On the basis of application, the market is segregated into oncology, peripheral vascular diseases, urology and nephrology, neurology and others. On the basis of end user, the market is segmented into hospitals & clinics, ambulatory surgical centers and others. By region market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).Major key players that operate in the global vascular embolization market are Abbott Laboratories., Balt Group, Boston Scientific Corporation, Cook Medical, Johnson and Johnson, Kaneka Corporation, Medtronic Plc, Merit Medical, Stryker Corporation, and Terumo Medical Corporation.
Key Benefits For Stakeholders
This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the vascular embolization market analysis from 2021 to 2031 to identify the prevailing vascular embolization market opportunities.
The market research is offered along with information related to key drivers, restraints, and opportunities.
Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
In-depth analysis of the vascular embolization market segmentation assists to determine the prevailing market opportunities.
Major countries in each region are mapped according to their revenue contribution to the global market.
Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
The report includes the analysis of the regional as well as global vascular embolization market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Product
Embolic Agents
Type
Liquid Embolic Agents
Microspheres
Embolization Devices
Type
Coils
Detachable Balloons
Embolic Plug
Support Devices
By Application
Oncology
Peripheral Vascular Diseases
Urology and Nephrology
Neurology
Others
By End User
Hospitals and Clinics
Ambulatory Surgical Centers
Others
By Region
North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest Of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest Of Asia-Pacific
LAMEA
Brazil
Saudi Arabia
South Africa
Rest Of LAMEA
Key Market Players
BOSTON SCIENTIFIC CORPORATION
MERIT MEDICAL SYSTEMS
TERUMO CORPORATION
MEDTRONIC PLC
ABBOTT LABORATORIES
DEPUY SYNTHES (J&J MEDICAL DEVICES)
COOK MEDICAL
BALT
KANEKA CORPORATION
STRYKER CORPORATION
Please Note: It will take 7-10 business days to complete the report upon order confirmation.
- CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
- CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter’s five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- CHAPTER 4: VASCULAR EMBOLIZATION MARKET, BY PRODUCT
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Embolic Agents
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.2.4 Embolic Agents Vascular Embolization Market by Type
- 4.2.4.1 Liquid Embolic Agents Market size and forecast, by region
- 4.2.4.2 Microspheres Market size and forecast, by region
- 4.3 Embolization Devices
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.3.4 Embolization Devices Vascular Embolization Market by Type
- 4.3.4.1 Coils Market size and forecast, by region
- 4.3.4.2 Detachable Balloons Market size and forecast, by region
- 4.3.4.3 Embolic Plug Market size and forecast, by region
- 4.3.4.4 Support Devices Market size and forecast, by region
- CHAPTER 5: VASCULAR EMBOLIZATION MARKET, BY APPLICATION
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Oncology
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Peripheral Vascular Diseases
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Urology and Nephrology
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Neurology
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- 5.6 Others
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country
- CHAPTER 6: VASCULAR EMBOLIZATION MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospitals and Clinics
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Ambulatory Surgical Centers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Others
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
- CHAPTER 7: VASCULAR EMBOLIZATION MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product
- 7.2.2.1 North America Embolic Agents Vascular Embolization Market by Type
- 7.2.2.2 North America Embolization Devices Vascular Embolization Market by Type
- 7.2.3 North America Market size and forecast, by Application
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Product
- 7.2.5.1.2 Market size and forecast, by Application
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Product
- 7.2.5.2.2 Market size and forecast, by Application
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Product
- 7.2.5.3.2 Market size and forecast, by Application
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product
- 7.3.2.1 Europe Embolic Agents Vascular Embolization Market by Type
- 7.3.2.2 Europe Embolization Devices Vascular Embolization Market by Type
- 7.3.3 Europe Market size and forecast, by Application
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Product
- 7.3.5.1.2 Market size and forecast, by Application
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 France
- 7.3.5.2.1 Market size and forecast, by Product
- 7.3.5.2.2 Market size and forecast, by Application
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 UK
- 7.3.5.3.1 Market size and forecast, by Product
- 7.3.5.3.2 Market size and forecast, by Application
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Italy
- 7.3.5.4.1 Market size and forecast, by Product
- 7.3.5.4.2 Market size and forecast, by Application
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Spain
- 7.3.5.5.1 Market size and forecast, by Product
- 7.3.5.5.2 Market size and forecast, by Application
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Product
- 7.3.5.6.2 Market size and forecast, by Application
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product
- 7.4.2.1 Asia-Pacific Embolic Agents Vascular Embolization Market by Type
- 7.4.2.2 Asia-Pacific Embolization Devices Vascular Embolization Market by Type
- 7.4.3 Asia-Pacific Market size and forecast, by Application
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 China
- 7.4.5.1.1 Market size and forecast, by Product
- 7.4.5.1.2 Market size and forecast, by Application
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 Japan
- 7.4.5.2.1 Market size and forecast, by Product
- 7.4.5.2.2 Market size and forecast, by Application
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 India
- 7.4.5.3.1 Market size and forecast, by Product
- 7.4.5.3.2 Market size and forecast, by Application
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 Australia
- 7.4.5.4.1 Market size and forecast, by Product
- 7.4.5.4.2 Market size and forecast, by Application
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 South Korea
- 7.4.5.5.1 Market size and forecast, by Product
- 7.4.5.5.2 Market size and forecast, by Application
- 7.4.5.5.3 Market size and forecast, by End User
- 7.4.5.6 Rest of Asia-Pacific
- 7.4.5.6.1 Market size and forecast, by Product
- 7.4.5.6.2 Market size and forecast, by Application
- 7.4.5.6.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product
- 7.5.2.1 LAMEA Embolic Agents Vascular Embolization Market by Type
- 7.5.2.2 LAMEA Embolization Devices Vascular Embolization Market by Type
- 7.5.3 LAMEA Market size and forecast, by Application
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Product
- 7.5.5.1.2 Market size and forecast, by Application
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Product
- 7.5.5.2.2 Market size and forecast, by Application
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Product
- 7.5.5.3.2 Market size and forecast, by Application
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Product
- 7.5.5.4.2 Market size and forecast, by Application
- 7.5.5.4.3 Market size and forecast, by End User
- CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
- CHAPTER 9: COMPANY PROFILES
- 9.1 BOSTON SCIENTIFIC CORPORATION
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 MERIT MEDICAL SYSTEMS
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 TERUMO CORPORATION
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 MEDTRONIC PLC
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 ABBOTT LABORATORIES
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 DEPUY SYNTHES (J&J MEDICAL DEVICES)
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 COOK MEDICAL
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 BALT
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 KANEKA CORPORATION
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 STRYKER CORPORATION
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments
- LIST OF TABLES
- TABLE 1. GLOBAL VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 2. VASCULAR EMBOLIZATION MARKET, FOR EMBOLIC AGENTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 3. VASCULAR EMBOLIZATION MARKET FOR EMBOLIC AGENTS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 4. GLOBAL EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 5. VASCULAR EMBOLIZATION MARKET, FOR LIQUID EMBOLIC AGENTS, BY REGION, 2021-2031 ($MILLION)
- TABLE 6. VASCULAR EMBOLIZATION MARKET, FOR MICROSPHERES, BY REGION, 2021-2031 ($MILLION)
- TABLE 7. VASCULAR EMBOLIZATION MARKET, FOR EMBOLIZATION DEVICES, BY REGION, 2021-2031 ($MILLION)
- TABLE 8. VASCULAR EMBOLIZATION MARKET FOR EMBOLIZATION DEVICES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 9. GLOBAL EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 10. VASCULAR EMBOLIZATION MARKET, FOR COILS, BY REGION, 2021-2031 ($MILLION)
- TABLE 11. VASCULAR EMBOLIZATION MARKET, FOR DETACHABLE BALLOONS, BY REGION, 2021-2031 ($MILLION)
- TABLE 12. VASCULAR EMBOLIZATION MARKET, FOR EMBOLIC PLUG, BY REGION, 2021-2031 ($MILLION)
- TABLE 13. VASCULAR EMBOLIZATION MARKET, FOR SUPPORT DEVICES, BY REGION, 2021-2031 ($MILLION)
- TABLE 14. GLOBAL VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 15. VASCULAR EMBOLIZATION MARKET, FOR ONCOLOGY, BY REGION, 2021-2031 ($MILLION)
- TABLE 16. VASCULAR EMBOLIZATION MARKET FOR ONCOLOGY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 17. VASCULAR EMBOLIZATION MARKET, FOR PERIPHERAL VASCULAR DISEASES, BY REGION, 2021-2031 ($MILLION)
- TABLE 18. VASCULAR EMBOLIZATION MARKET FOR PERIPHERAL VASCULAR DISEASES, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 19. VASCULAR EMBOLIZATION MARKET, FOR UROLOGY AND NEPHROLOGY, BY REGION, 2021-2031 ($MILLION)
- TABLE 20. VASCULAR EMBOLIZATION MARKET FOR UROLOGY AND NEPHROLOGY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 21. VASCULAR EMBOLIZATION MARKET, FOR NEUROLOGY, BY REGION, 2021-2031 ($MILLION)
- TABLE 22. VASCULAR EMBOLIZATION MARKET FOR NEUROLOGY, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 23. VASCULAR EMBOLIZATION MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 24. VASCULAR EMBOLIZATION MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 25. GLOBAL VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 26. VASCULAR EMBOLIZATION MARKET, FOR HOSPITALS AND CLINICS, BY REGION, 2021-2031 ($MILLION)
- TABLE 27. VASCULAR EMBOLIZATION MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 28. VASCULAR EMBOLIZATION MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 29. VASCULAR EMBOLIZATION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 30. VASCULAR EMBOLIZATION MARKET, FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
- TABLE 31. VASCULAR EMBOLIZATION MARKET FOR OTHERS, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 32. VASCULAR EMBOLIZATION MARKET, BY REGION, 2021-2031 ($MILLION)
- TABLE 33. NORTH AMERICA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 34. NORTH AMERICA EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 35. NORTH AMERICA EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 36. NORTH AMERICA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 37. NORTH AMERICA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 38. NORTH AMERICA VASCULAR EMBOLIZATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 39. U.S. VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 40. U.S. VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 41. U.S. VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 42. CANADA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 43. CANADA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 44. CANADA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 45. MEXICO VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 46. MEXICO VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 47. MEXICO VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 48. EUROPE VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 49. EUROPE EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 50. EUROPE EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 51. EUROPE VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 52. EUROPE VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 53. EUROPE VASCULAR EMBOLIZATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 54. GERMANY VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 55. GERMANY VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 56. GERMANY VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 57. FRANCE VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 58. FRANCE VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 59. FRANCE VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 60. UK VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 61. UK VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 62. UK VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 63. ITALY VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 64. ITALY VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 65. ITALY VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 66. SPAIN VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 67. SPAIN VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 68. SPAIN VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 69. REST OF EUROPE VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 70. REST OF EUROPE VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 71. REST OF EUROPE VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 72. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 73. ASIA-PACIFIC EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 74. ASIA-PACIFIC EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 75. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 76. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 77. ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 78. CHINA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 79. CHINA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 80. CHINA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 81. JAPAN VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 82. JAPAN VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 83. JAPAN VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 84. INDIA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 85. INDIA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 86. INDIA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 87. AUSTRALIA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 88. AUSTRALIA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 89. AUSTRALIA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 90. SOUTH KOREA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 91. SOUTH KOREA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 92. SOUTH KOREA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 93. REST OF ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 94. REST OF ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 95. REST OF ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 96. LAMEA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 97. LAMEA EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 98. LAMEA EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET, BY TYPE, 2021-2031 ($MILLION)
- TABLE 99. LAMEA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 100. LAMEA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 101. LAMEA VASCULAR EMBOLIZATION MARKET, BY COUNTRY, 2021-2031 ($MILLION)
- TABLE 102. BRAZIL VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 103. BRAZIL VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 104. BRAZIL VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 105. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 106. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 107. SAUDI ARABIA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 108. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 109. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 110. SOUTH AFRICA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 111. REST OF LAMEA VASCULAR EMBOLIZATION MARKET, BY PRODUCT, 2021-2031 ($MILLION)
- TABLE 112. REST OF LAMEA VASCULAR EMBOLIZATION MARKET, BY APPLICATION, 2021-2031 ($MILLION)
- TABLE 113. REST OF LAMEA VASCULAR EMBOLIZATION MARKET, BY END USER, 2021-2031 ($MILLION)
- TABLE 114.BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT
- TABLE 115.BOSTON SCIENTIFIC CORPORATION: OPERATING SEGMENTS
- TABLE 116.BOSTON SCIENTIFIC CORPORATION: PRODUCT PORTFOLIO
- TABLE 117.BOSTON SCIENTIFIC CORPORATION: NET SALES,
- TABLE 118.BOSTON SCIENTIFIC CORPORATION: KEY STRATERGIES
- TABLE 119.MERIT MEDICAL SYSTEMS: COMPANY SNAPSHOT
- TABLE 120.MERIT MEDICAL SYSTEMS: OPERATING SEGMENTS
- TABLE 121.MERIT MEDICAL SYSTEMS: PRODUCT PORTFOLIO
- TABLE 122.MERIT MEDICAL SYSTEMS: NET SALES,
- TABLE 123.MERIT MEDICAL SYSTEMS: KEY STRATERGIES
- TABLE 124.TERUMO CORPORATION: COMPANY SNAPSHOT
- TABLE 125.TERUMO CORPORATION: OPERATING SEGMENTS
- TABLE 126.TERUMO CORPORATION: PRODUCT PORTFOLIO
- TABLE 127.TERUMO CORPORATION: NET SALES,
- TABLE 128.TERUMO CORPORATION: KEY STRATERGIES
- TABLE 129.MEDTRONIC PLC: COMPANY SNAPSHOT
- TABLE 130.MEDTRONIC PLC: OPERATING SEGMENTS
- TABLE 131.MEDTRONIC PLC: PRODUCT PORTFOLIO
- TABLE 132.MEDTRONIC PLC: NET SALES,
- TABLE 133.MEDTRONIC PLC: KEY STRATERGIES
- TABLE 134.ABBOTT LABORATORIES: COMPANY SNAPSHOT
- TABLE 135.ABBOTT LABORATORIES: OPERATING SEGMENTS
- TABLE 136.ABBOTT LABORATORIES: PRODUCT PORTFOLIO
- TABLE 137.ABBOTT LABORATORIES: NET SALES,
- TABLE 138.ABBOTT LABORATORIES: KEY STRATERGIES
- TABLE 139.DEPUY SYNTHES (J&J MEDICAL DEVICES): COMPANY SNAPSHOT
- TABLE 140.DEPUY SYNTHES (J&J MEDICAL DEVICES): OPERATING SEGMENTS
- TABLE 141.DEPUY SYNTHES (J&J MEDICAL DEVICES): PRODUCT PORTFOLIO
- TABLE 142.DEPUY SYNTHES (J&J MEDICAL DEVICES): NET SALES,
- TABLE 143.DEPUY SYNTHES (J&J MEDICAL DEVICES): KEY STRATERGIES
- TABLE 144.COOK MEDICAL: COMPANY SNAPSHOT
- TABLE 145.COOK MEDICAL: OPERATING SEGMENTS
- TABLE 146.COOK MEDICAL: PRODUCT PORTFOLIO
- TABLE 147.COOK MEDICAL: NET SALES,
- TABLE 148.COOK MEDICAL: KEY STRATERGIES
- TABLE 149.BALT: COMPANY SNAPSHOT
- TABLE 150.BALT: OPERATING SEGMENTS
- TABLE 151.BALT: PRODUCT PORTFOLIO
- TABLE 152.BALT: NET SALES,
- TABLE 153.BALT: KEY STRATERGIES
- TABLE 154.KANEKA CORPORATION: COMPANY SNAPSHOT
- TABLE 155.KANEKA CORPORATION: OPERATING SEGMENTS
- TABLE 156.KANEKA CORPORATION: PRODUCT PORTFOLIO
- TABLE 157.KANEKA CORPORATION: NET SALES,
- TABLE 158.KANEKA CORPORATION: KEY STRATERGIES
- TABLE 159.STRYKER CORPORATION: COMPANY SNAPSHOT
- TABLE 160.STRYKER CORPORATION: OPERATING SEGMENTS
- TABLE 161.STRYKER CORPORATION: PRODUCT PORTFOLIO
- TABLE 162.STRYKER CORPORATION: NET SALES,
- TABLE 163.STRYKER CORPORATION: KEY STRATERGIES
- LIST OF FIGURES
- FIGURE 1.VASCULAR EMBOLIZATION MARKET SEGMENTATION
- FIGURE 2.VASCULAR EMBOLIZATION MARKET,2021-2031
- FIGURE 3.VASCULAR EMBOLIZATION MARKET,2021-2031
- FIGURE 4. TOP INVESTMENT POCKETS, BY REGION
- FIGURE 5.PORTER FIVE-1
- FIGURE 6.PORTER FIVE-2
- FIGURE 7.PORTER FIVE-3
- FIGURE 8.PORTER FIVE-4
- FIGURE 9.PORTER FIVE-5
- FIGURE 10.TOP PLAYER POSITIONING
- FIGURE 11.VASCULAR EMBOLIZATION MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
- FIGURE 12.VASCULAR EMBOLIZATION MARKET,BY PRODUCT,2021(%)
- FIGURE 13.COMPARATIVE SHARE ANALYSIS OF EMBOLIC AGENTS VASCULAR EMBOLIZATION MARKET,2021-2031(%)
- FIGURE 14.COMPARATIVE SHARE ANALYSIS OF EMBOLIZATION DEVICES VASCULAR EMBOLIZATION MARKET,2021-2031(%)
- FIGURE 15.VASCULAR EMBOLIZATION MARKET,BY APPLICATION,2021(%)
- FIGURE 16.COMPARATIVE SHARE ANALYSIS OF ONCOLOGY VASCULAR EMBOLIZATION MARKET,2021-2031(%)
- FIGURE 17.COMPARATIVE SHARE ANALYSIS OF PERIPHERAL VASCULAR DISEASES VASCULAR EMBOLIZATION MARKET,2021-2031(%)
- FIGURE 18.COMPARATIVE SHARE ANALYSIS OF UROLOGY AND NEPHROLOGY VASCULAR EMBOLIZATION MARKET,2021-2031(%)
- FIGURE 19.COMPARATIVE SHARE ANALYSIS OF NEUROLOGY VASCULAR EMBOLIZATION MARKET,2021-2031(%)
- FIGURE 20.COMPARATIVE SHARE ANALYSIS OF OTHERS VASCULAR EMBOLIZATION MARKET,2021-2031(%)
- FIGURE 21.VASCULAR EMBOLIZATION MARKET,BY END USER,2021(%)
- FIGURE 22.COMPARATIVE SHARE ANALYSIS OF HOSPITALS AND CLINICS VASCULAR EMBOLIZATION MARKET,2021-2031(%)
- FIGURE 23.COMPARATIVE SHARE ANALYSIS OF AMBULATORY SURGICAL CENTERS VASCULAR EMBOLIZATION MARKET,2021-2031(%)
- FIGURE 24.COMPARATIVE SHARE ANALYSIS OF OTHERS VASCULAR EMBOLIZATION MARKET,2021-2031(%)
- FIGURE 25.VASCULAR EMBOLIZATION MARKET BY REGION,2021
- FIGURE 26.U.S. VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 27.CANADA VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 28.MEXICO VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 29.GERMANY VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 30.FRANCE VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 31.UK VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 32.ITALY VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 33.SPAIN VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 34.REST OF EUROPE VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 35.CHINA VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 36.JAPAN VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 37.INDIA VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 38.AUSTRALIA VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 39.SOUTH KOREA VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 40.REST OF ASIA-PACIFIC VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 41.BRAZIL VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 42.SAUDI ARABIA VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 43.SOUTH AFRICA VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 44.REST OF LAMEA VASCULAR EMBOLIZATION MARKET,2021-2031($MILLION)
- FIGURE 45. TOP WINNING STRATEGIES, BY YEAR
- FIGURE 46. TOP WINNING STRATEGIES, BY DEVELOPMENT
- FIGURE 47. TOP WINNING STRATEGIES, BY COMPANY
- FIGURE 48.PRODUCT MAPPING OF TOP 10 PLAYERS
- FIGURE 49.COMPETITIVE DASHBOARD
- FIGURE 50.COMPETITIVE HEATMAP OF TOP 10 KEY PLAYERS
- FIGURE 51.BOSTON SCIENTIFIC CORPORATION.: NET SALES ,($MILLION)
- FIGURE 52.MERIT MEDICAL SYSTEMS.: NET SALES ,($MILLION)
- FIGURE 53.TERUMO CORPORATION.: NET SALES ,($MILLION)
- FIGURE 54.MEDTRONIC PLC.: NET SALES ,($MILLION)
- FIGURE 55.ABBOTT LABORATORIES.: NET SALES ,($MILLION)
- FIGURE 56.DEPUY SYNTHES (J&J MEDICAL DEVICES).: NET SALES ,($MILLION)
- FIGURE 57.COOK MEDICAL.: NET SALES ,($MILLION)
- FIGURE 58.BALT.: NET SALES ,($MILLION)
- FIGURE 59.KANEKA CORPORATION.: NET SALES ,($MILLION)
- FIGURE 60.STRYKER CORPORATION.: NET SALES ,($MILLION)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook